INTRODUCTION
Carcinogenic nitrosamines, such as dimethylnitrosamine (DMN), are metabolized at the α-carbon by cytochrome P450 (CYP) to form the active metabolite (methyldiazohydroxide) by demethylation accompanied with the formation of formaldehyde. [1] [2] [3] It is well-known that CYP2E1 and CYP2A6 are responsible for activation of carcinogenic nitrosamines, and CYP2E1 may be the major enzymes catalyzing the metabolic N-demethylation of DMN in human liver microsomes. [4] [5] [6] [7] [8] Our previous study indicated that 3,4-dichloroaniline (3,4-diCl-A) and 3,5-diCl-A showed potent inhibition of recombinant human CYP2E1 (IC 50 = 8.0 and 9.2 µM, respectively) and no inhibition of CYP1A2 (IC 50 > 200 µM). 9) Moreover, the inhibitory effects of the anilines on CYP2E1 were widely affected by the substituted halogen species, number, and positions. 9) In this study, nine halogenated anilines, 3,5-difluoroaniline (3,5-diF-A), 3,4,5-trifluoroaniline (3,4,5-triF-A), 2,6-diCl-A, 3,4-diCl-A, 3,5-diCl-A, 2,3,4-trichloroaniline (2,3,4-triCl-A), 2,4,6-triCl-A, 3,4,5-triCl-A, and 2,6-dibromoaniline (2,6-diBr-A), were subjected to analysis of their inhibitory effects on metabolic activation of DMN in human liver microsomes to investigate the structure-CYP2E1/2A6 selectivity relationships and CYP-selective metabolic activation of DMN.
MATERIALS AND METHODS
Materials ---7-Fluoro-4-methylquinoline and 7-fluoro-3-hydroxy-4-methylquinoline were synthesized as described in our previous report. 10) Pooled and individual human liver microsome preparations (donor Nos. HG3, HK25, HK37, HG43, HG56, HG64, HG89, HG93, and HG95) and insect microsome preparations from bacurovirus-infected insect cells expressing CYP2E1, CYP2A6, and CYP1A2, each coexpressed with NADPH-CYP oxidoreductase, were purchased from Gentest Co. Inhibition of CYP1A2 Activity Determined by 7-Fluoro-4-Methylquinoline 3-Hydroxylation ---In our previous study, 9) it was demonstrated that the fluorescence mothod for determination of quinoline 3-hydroxylation might be useful for monitoring CYP2E1 activity. Human CYP1A2 was reported as a secondly major isoform involved in the formation of 3-hydroxyquinoline.
11) Among several quinoline derivatives, 7-fluoro-4-methylquinoline was effectively metabolized by CYP1A2 to a fluorescent metabolite, 7-fluoro-3-hydroxy-4-methylquinoline (460 nm emission and 355 nm excitation). The incubation mixture (50 µl in a 1.5 ml microtube) contained 0.1 M potassium phosphate buffer (pH 7.4), 1.3 mM NADP, 3.3 mM G6P, 3.3 mM MgCl 2 , 0.08 units of G6P dehydrogenase, 0.5 mM 7-fluoro-4-methylquinoline, inhibitor (0 to 1000 µM), and 1.0 pmol CYP (1.7 µg protein). After incubation at 37°C for 60 min, the resulting metabolites were extracted with 2.5 volumes of ethyl acetate, and the organic solvent layer was evaporated. The residue was dissolved in 200 µl of 0.5 M Tris base-10% dimethyl sulfoxide (DMSO) solution and added to wells in a 96-well plate. The production of fluorescent 7-fluoro-3-hydroxy-4-methylquinoline (460 nm emission and 355 nm excitation) was recorded with an ARVO1420 Multilabel Counter and the relative fluorescence was compared to the calibration curve. The inhibitory effect was calculated by IC 50 . At least three independent experiments were performed.
Inhibition of CYP2A6 activity by halogenated anilines was determined by coumarin-7-hydroxylation as in the previous report. 12, 13) Metabolism of Dimethylnitrosamine in Human Liver Microsomes ---The incubation mixture (320 µl in a 1.5 ml microtube) contained 0.1 M potassium phosphate buffer (pH 7.4), 1.3 mM β-NADPH, 3.3 mM MgCl 2 , 5 mM DMN, inhibitor (0 to 500 µM), and 0.16 mg human liver microsomes. After incubation at 37°C for 60 min, the production of formaldehyde was measured by FormaldehydeTest-Wako. Briefly, the resulting mixture was mixed with an equal volume of 5 M NaOH and centrifuged at 10,000 × g for 10 min. The supernatant (600 µl) was allowed to react with 300 µl of the reacting reagent (4-amino-3-hydrazino-5-mercapto-1,2,4-triazol) at room temperature for 15 min and the oxidizing reagent (potassium periodate) was added under vortex mixing for 20 second. The production of 7-mercaptotriazinotetrazine was recorded at the wavelength of 550 nm, and relative absorbance was compared to the calibration curve. At least three independent experiments were performed.
RESULTS AND DISCUSSION
The metabolism of DMN in human liver microsomes was assayed to evaluate CYP-selectivity in DMN metabolic activation, using 9 individual human liver microsomes (HG3, HK25, HK37, HG43, HG56, HG64, HG89, HG93, and HG95) and pooled human liver microsomes. The results shown in Table 1 demonstrate the inter-individual diversity of the metabolic activity with DMN measured by formaldehyde production. The metabolic activity with DMN ranged from 0.14 to 1.07 nmol/min/mg protein among the 9 microsome samples tested. The metabolic activity obtained with the pooled human liver microsome preparation was approximately equal to the average level of the 9 individual samples. Then, the metabolic activity with DMN was compared with the CYP2E1-and CYP2A6-selective catalytic activities of each microsomal preparation as given in the GENTEST catalog ( Table 1) . The metabolic activity significantly correlated with the CYP2E1-selective catalytic activity (r = 0.81, p < 0.01), but not with the CYP2A6-selective catalytic activity (r = 0.26) of each microsome preparation. The result confirmed that CYP2E1 is the principal enzyme responsible for the metabolic activation of DMN in human liver microsomes as shown in the previous studies. [4] [5] [6] [7] [8] Nine halogenated anilines, 3,5-diF-A, 3,4,5-triF-A, 2,6-diCl-A, 3,4-diCl-A, 3,5-diCl-A, 2,3,4-triCl-A, 2,4,6-triCl-A, 3,4,5-triCl-A, and 2,6-diBr-A, were subjected to analysis of their inhibitory effects on metabolic activation of DMN in human liver microsome (HG56) to evaluate their CYP2E1/2A6-selective inhibition. The inhibitory activities (IC 50 ) of these anilines on human recombinant CYP2E1, CYP1A2, and CYP2A6 activities are shown in Table 2 . Most of these anilines showed no remarkable inhibition of recombinant CYP1A2 activity and only 3,4,5-triCl-A showed moderate inhibition of CYP1A2. The IC 50 values of these anilines on human recombinant CYP2E1 and CYP2A6 activities varied considerably with the substituted halogen species, number, and positions. The IC 50 values of these anilines on human recombinant CYP2E1 and CYP2A6 activity ranged from 8.0 to 549 µM and 2.9 to 232 µM, respectively. Our preliminary study showed that 3,4-diCl-A and 3,5-diCl-A inhibited CYP2E1 activity by the competition mechanism (Ki = 0.53 ± 0.01 and 0.92 ± 0.03 µM, respectively). The CYP2E1 selectivities of these anilines, the ratios of the IC 50 values of these anilines on CYP2A6 to those on CYP2E1, ranged from 0.1-to 5.2-fold. Although 3,5-diF-A and 3,4,5-triF-A showed moderate inhibition of recombinant CYP2E1 activity, the CYP2E1 selectivities of the fluorinated anilines were sufficiently higher than those of all other anilines. On the other hand, trichlorinated anilines, 2,3,4-triCl-A, 2,4,6-triCl-A, and 3,4,5-triCl-A, and 2,6-diBr-A showed very low CYP2E1 selectivities, and these lipophilic and large anilines were rather CYP2A6-selective. These results suggested that CYP2E1-selective inhibition by halogenated anilines were variable with the lipohilicity and molecular size, and oligofluorine substitution may be responsible for enhancement of CYP2E1 selectivity. The IC 50 values of these anilines on DMN metabolic activation in human liver microsomes are shown in Table 3 . HG56 was used because it had the highest total P450 content (480 pmol/mg) and showed moderate activity in DMN metabolism. The IC 50 values of these anilines on DMN metabolic activation in human liver microsomes ranged from 3.6 to 338 µM. Surprisingly, the ranges of the IC 50 of these anilines on DMN metabolism in human liver microsomes, in which many CYP-isoforms exist at various levels, were very similar with those on human recombinant CYP2E1 and CYP2A6 activities. Moreover, as shown in Fig. 1 , the IC 50 of these anilines on DMN metabolism in human liver microsomes significantly correlated with the IC 50 on human recombinant CYP2E1 activity (r = 0.89, p < 0.01) but not with the IC 50 on CYP2A6. The results suggested that 9 halogenated anilines inhibited CYP2E1 activity in human liver microsomes to the same degree as in human recombinant CYP2E1.
In conclusion, these results suggest that these halogenated anilines may be useful as indicators of CYP-selectivity involved in metabolic activation of nitrosamines in human liver microsomes. 
